Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Organic Guidance; NAD Review; FTC Enforcement; FDA Warning

This article was originally published in The Tan Sheet

Executive Summary

USDA organic guidance; NAD challenges Akeso’s “doctor recommended” claims; new name for NCCAM proposed; FTC finalizes decree with GeneLink; Fortune Hi-Tech Marketing resolves pyramid allegations; CDJ supplements are unapproved new drugs; more news In Brief.

You may also be interested in...



More Problems With Lead In Supplements: Health And Wellness Industry News Roundup

Another recall by Chicago firm Ton Shen Health; Mannatech rides Asia-Pacific growth; and more news in brief.

In Brief: laxatives warning, FTC settlement, ChromaDex inks 5LINX deal

Sodium phosphate laxatives linked to SAERs; FTC scrutinizes personalized supplement claims; NAD refers Xlear LLC to FTC; ChromaDex inks marketing deal with 5LINX; CVS launches vitamin sales, info hub on its website; Star Scientific shareholder suit proceeds.

Fortune Hi-Tech Complaint Could Intensify Scrutiny Of Multilevel Marketers

FTC worked with state authorities in an investigation of multilevel marketer Fortune Hi-Tech that led to a court order shutting down the firm. Meanwhile, nutritional and cosmetic product firm Nu Skin offers a defense against criticism of the multilevel business model after investors target Herbalife.

Topics

UsernamePublicRestriction

Register

PS106920

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel